Daiichi Sankyo Co Ltd's for control of Ranbaxy Laboratories Ltd that pharmaceutical companies have a major appetite for generic drugmakers despite concerns about differences in their business models.
Reuters
http://in.reuters.com/article/asiaCompanyAndMarkets/
idINN1144380420080611?sp=true
No comments:
Post a Comment